Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 06.09.17 in Vol 6, No 9 (2017): September

This paper is in the following e-collection/theme issue:

Works citing "The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease"

Michelle van der Linden, Kim Meeuwis, Colette van Hees, Eleonora van Dorst, Johan Bulten, Tjalling Bosse, Joanna IntHout, Dorry Boll, Brigitte Slangen, Manon van Seters, Marc van Beurden, Mariëtte van Poelgeest, Joanne de Hullu

JMIR Res Protoc 2017 (Sep 06); 6(9):e178 

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.7503):

(note that this is only a small subset of citations)

  1. Wohlmuth C, Wohlmuth‐Wieser I. Vulvar malignancies: an interdisciplinary perspective. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2019;17(12):1257
    CrossRef
  2. Asel M, LeBoeuf NR. Extramammary Paget's Disease. Hematology/Oncology Clinics of North America 2019;33(1):73
    CrossRef
  3. Wohlmuth C, Wohlmuth‐Wieser I. Vulvamalignome: eine interdisziplinäre Betrachtung. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2019;17(12):1257
    CrossRef
  4. Angelopoulou A, Alexandris N, Konstantinou E, Mesiakaris K, Zanidis C, Farsalinos K, Poulas K. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19. Environmental Research 2020;188:109858
    CrossRef
  5. Bertling F, Kuntz T, Koushk-Jalali B, Oellig F, Wieland U, Kreuter A. Persistierender livid-rötlicher flacher Knoten in der Leiste. Der Hautarzt 2020;71(5):399
    CrossRef
  6. van der Linden M, van Esch E, Bulten J, Dreef E, Massuger L, van der Steen S, Bosse T, de Hullu J, van Poelgeest M. The immune cell infiltrate in the microenvironment of vulvar Paget disease. Gynecologic Oncology 2018;151(3):453
    CrossRef
  7. Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A. Interventions for the treatment of Paget's disease of the vulva. Cochrane Database of Systematic Reviews 2019;2019(6)
    CrossRef
  8. Carton I, Lebreton M, Tesson C, Henno S, Lavoué V, Levêque J, Nyangoh-Timoh K. Paget's disease of the vulva: A challenge for the gynaecologist. Journal of Gynecology Obstetrics and Human Reproduction 2021;50(1):101896
    CrossRef
  9. Preti M, Micheletti L, Borella F, Cosma S, Marrazzu A, Gallio N, Privitera S, Tancredi A, Bevilacqua F, Benedetto C. Vulvar Paget's disease and stromal invasion: Clinico-pathological features and survival outcomes. Surgical Oncology 2021;38:101581
    CrossRef
  10. Preti M, Joura E, Vieira-Baptista P, Van Beurden M, Bevilacqua F, Bleeker MCG, Bornstein J, Carcopino X, Chargari C, Cruickshank ME, Erzeneoglu BE, Gallio N, Heller D, Kesic V, Reich O, Stockdale CK, Temiz BE, Woelber L, Planchamp F, Zodzika J, Querleu D, Gultekin M. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions. Journal of Lower Genital Tract Disease 2022;26(3):229
    CrossRef
  11. Borella F, Preti M, Vieira-Baptista P, Pérez-López FR, Bertero L, Gallio N, Micheletti L, Benedetto C. Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream. Maturitas 2022;163:23
    CrossRef
  12. van der Linden M, van Hees CL, van Beurden M, Bulten J, van Dorst EB, Esajas MD, Meeuwis KA, Boll D, van Poelgeest MI, de Hullu JA. The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease. American Journal of Obstetrics and Gynecology 2022;227(2):250.e1
    CrossRef
  13. Preti M, Joura E, Vieira-Baptista P, Van Beurden M, Bevilacqua F, Bleeker MCG, Bornstein J, Carcopino X, Chargari C, Cruickshank ME, Erzeneoglu BE, Gallio N, Heller D, Kesic V, Reich O, Stockdale CK, Esat Temiz B, Woelber L, Planchamp F, Zodzika J, Querleu D, Gultekin M. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions. International Journal of Gynecologic Cancer 2022;32(7):830
    CrossRef
  14. Garcia A, Nelson K, Patel V. Emerging therapies for rare cutaneous cancers: A systematic review. Cancer Treatment Reviews 2021;100:102266
    CrossRef
  15. Bouceiro-Mendes R, Mendonça-Sanches M, Soares-de-Almeida L, Correia-Fonseca I. A Case of Chronic and Relapsing Paget Disease of the Vulva. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 2019;41(06):412
    CrossRef
  16. Mayo-Martínez F, Moro R, Millán-Esteban D, Ríos-Viñuela E, Bautista IJ, Nagore E, Sanmartín O, Llombart B. Topical Imiquimod in Primary Cutaneous Extramammary Paget’s Disease: A Systematic Review. Cancers 2023;15(23):5665
    CrossRef
  17. Hatta N, Ogata D, Asai J, Maekawa T, Ito T, Takenouchi T, Kiniwa Y, Miyashita A, Miyagawa T, Muto I, Yamamoto Y, Nagano T, Kiyohara Y, Nakano E, Ohe S, Yamaguchi B, Fukuyama M, Matsuya T, Tsutsumida A, Namikawa K, Yamazaki N. Recent treatment and prognosis in 643 patients with extramammary Paget's disease. Experimental Dermatology 2024;33(2)
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/resprot.7503):

  1. Hirchenhain C, Dornhöfer N. Blickdiagnosen Gynäkologie/ Geburtshilfe. 2022. :137
    CrossRef